Biotest Aktiengesellschaft reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was EUR 115.9 million compared to EUR 120 million a year ago. Net loss was EUR 4.9 million compared to EUR 14.1 million a year ago. Basic loss per share from continuing operations was EUR 0.13 compared to EUR 0.37 a year ago.